You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 34 No. 8, August 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Catatonic Reactions to High-Potency Neuroleptic Drugs

Alan J. Gelenberg, MD; Michel R. Mandel, MD

Arch Gen Psychiatry. 1977;34(8):947-950.


Abstract

• Eight patients developed a syndrome marked by features of catatonia (including posturing, waxy flexibility, withdrawal and regression) and parkinsonism (including bradykinesia and rigidity) while receiving high-potency neuroleptic drugs. The syndrome had a gradual onset, responded slowly to withdrawal of the neuroleptic or use of an anticholinergic agent, but seemed to respond more rapidly to amantadine. The syndrome may easily be confused with a worsening of schizophrenic symptoms.



Author Affiliations

From the Special Studies Clinic, Department of Psychiatry, Massachusetts General Hospital, Erich Lindemann Mental Health Center, and Harvard Medical School, Boston.


Footnotes

Accepted for publication Feb 16, 1976.

Reprint requests to Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114 (Dr Gelenberg).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Catatonia Syndrome: Forgotten but Not Gone
Fink and Taylor
Arch Gen Psychiatry 2009;66:1173-1177.
FULL TEXT  

Fluphenazine-Induced Neuroleptic Malignant Syndrome in a Schizophrenic Patient
Aruna and Murungi
The Annals of Pharmacotherapy 2005;39:1131-1135.
ABSTRACT | FULL TEXT  

Catatonia With Thrombotic Thrombocytopenic Purpura
Yacoub et al.
Psychosomatics 2004;45:363-364.
FULL TEXT  

Episodically Remitting Akinetic Mutism Following Subarachnoid Hemorrhage
Burruss and Chacko
J. Neuropsychiatry Clin. Neurosi. 1999;11:100-102.
ABSTRACT | FULL TEXT  

Catatonia: Another Neuropsychiatric Presentation of Vitamin B12 Deficiency?
Catalano et al.
Psychosomatics 1998;39:456-460.
FULL TEXT  

'Catatonia' due to Disulfiram Toxicity
Fisher
Arch Neurol 1989;46:798-804.
ABSTRACT  

Neuroleptic Malignant Syndrome
Morris et al.
Arch Neurol 1980;37:462-463.
ABSTRACT  

Haloperidol for Acute Schizophrenic Patients: An Evaluation of Three Oral Regimens
Donlon et al.
Arch Gen Psychiatry 1980;37:691-695.
 

Predicting Drug-Free Improvement in Schizophrenic Psychosis
Marder et al.
Arch Gen Psychiatry 1979;36:1080-1085.
ABSTRACT  

Catatonic Stupor and Neuroleptic Drugs
Weinberger and Wyatt
JAMA 1978;239:1846-1846.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.